Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

BRAIN Biotech AG, DE0005203947

BRAIN Biotech AG, DE0005203947

03.09.2021 - 13:24:01

BRAIN Biotech AG: Correction of a release from 10/06/2020 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Notification of Major Holdings

1. Details of issuer Name: BRAIN Biotech AG Street: Darmst?dter Stra?e 34-36 Postal code: 64673 City: ZwingenbergGermany Legal Entity Identifier (LEI): 391200JKPVHLD6JLZ107 2. Reason for notification X Acquisition/disposal of shares with voting rights ? Acquisition/disposal of instruments ? Change of breakdown of voting rights X Other reason:Correction of a notification by Universal-Investment-GmbH, see 10. 3. Details of person subject to the notification obligation Legal entity: Montagu Private Equity LLPCity of registered office, country: London, United Kingdom 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.? 5. Date on which threshold was crossed or reached: 04 Jun 2020 6. Total positions ? % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) Total of both in % (7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG New 7.49 % 0.00 % 7.49 % 18055782 Previous notification n/a % n/a % n/a % / 7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG) ISIN Absolute In % ? Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) DE0005203947 0 1352500 0.00 % 7.49 % Total 1352500 7.49 % b.1. Instruments according to Sec. 38 (1) no. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % 0 0.00 % ? ? Total 0 0.00 % b.2. Instruments according to Sec. 38 (1) no. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % 0 0.00 % ? ? ? Total 0 0.00 % 8. Information in relation to the person subject to the notification obligation? Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more) Montagu Private Equity LLP % % % MLLP Holdings Ltd. % % % MPE (General Partner V) Ltd. % % % MPE (GP V) LP % % % Alpha LuxCo 1 SARL % % % Alpha LuxCo 2 SARL % % % Universal- Beteiligungs- und Servicegesellschaft mbH % % % Universal-Investment- Gesellschaft mbH 7.39 % % 7.39 % Universal-Investment Luxembourg S.A. % % % Montagu Private Equity LLP % % % MLLP Holdings Ltd. % % % Montagu V Nominees Ltd. % % % Alpha LuxCo 1 SARL % % % Alpha LuxCo 2 SARL % % % Universal- Beteiligungs- und Servicegesellschaft mbH % % % Universal-Investment- Gesellschaft mbH 7.39 % % 7.39 % Universal-Investment Luxembourg S.A. % % % 9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting:Proportion of voting rights Proportion of instruments Total of both % % % 10. Other explanatory remarks:With this and parallel correction notifications, the position of the notifying party as the ultimate parent company of the Universal Group pursuant to Section 35 (1) of the German Securities Trading Act (Wertpapierhandelsgesetz - WpHG) has been amended since 2017 with regard to the most recently submitted notifications of Universal Investment-Gesellschaft mbH. Further explanations and all notifications concerned can be found at: www.universal-investment.com/de/stimmrechtsmitteilungen? Date31 Aug 2021

03.09.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: BRAIN Biotech AG Darmst?dter Stra?e 34-36 64673 Zwingenberg

Germany Internet: www.brain-biotech.com ? End of News DGAP News Service

1231116??03.09.2021?

@ dgap.de